Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM)

Exploring the Impact of Monocytes in Myeloproliferative Neoplasia

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06462664

Acronym

EMYNEM

Enrollment

Registered

2024-06-17

Start date

2024-06-01

Completion date

2028-01-31

Last updated

2024-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myeloproliferative Neoplasm

Brief summary

Impact of monocytes on Myeloproliferative Neoplasm hematopoietic stem cell growth and differentiation in vitro

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Diagnosis of MPN in the participating center * Over 18 yo

Exclusion criteria

* Not able to consent

Design outcomes

Primary

Measure	Time frame
Proliferation and differentiation of hematopoitic stem/progenitor cells	2 years

Countries

France

Contacts

Primary ContactEric LIPPERT

eric.lippert@chu-brest.fr0298347033

Backup ContactWayne Corentin LAMBERT

wayne-corentin.lambert@chu-brest.fr

Outcome results